The rise and fall of mandatory surveillance for glycopeptide-resistant enterococcal bacteraemia in England

Journal of Infection

Volumn 68, Issue 4, 2014, Pages 401-403

  Gouliouris, T ^a,b,c   Peacock, S J ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIUM ISOLATE; CAUSAL ATTRIBUTION; CLOSTRIDIUM DIFFICILE INFECTION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EUROPE; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; LENGTH OF STAY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; RISK FACTOR; STAPHYLOCOCCUS AUREUS; UNITED STATES;

BACTEREMIA; DRUG RESISTANCE, BACTERIAL; ENGLAND; ENTEROCOCCUS; EPIDEMIOLOGICAL MONITORING; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE;

EID: 84895928512     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.01.009     Document Type: Letter

References (12)

1. Mikulska M., Viscoli C., Orasch C., Livermore D.M., Averbuch D., Cordonnier C., et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect 2014, 68:321-331.
2. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
3. European Centre for Disease Prevention and Control Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012 2013, ECDC, Stockholm, Available at:, [last accessed 22.11.13]. http://www.ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf.
4. Health Protection Agency English national point prevalence survey on healthcare-associated infections and antimicrobial use, 2011 2012, Health Protection Agency, London, Available at:, [last accessed 22.11.13]. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317134304594.
5. Lebreton F., van Schaik W., McGuire A.M., Godfrey P., Griggs A., Mazumdar V., et al. Emergence of epidemic multidrug-resistant Enterococcus faecium. MBio 2013, 4. e00534-13.
6. Reacher M.H., Shah A., Livermore D.M., Wale M.C., Graham C., Johnson A.P., et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br Med J 2000, 320:213-216.
7. Salgado C.D., Farr B.M. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003, 24:690-698.
8. Public Health England. Mandatory and voluntary surveillance data. Available at: [last accessed 22.11.13]. http://www.hpa.org.uk/.
9. Brown D.F.J., Brown N.M., Cookson B.D., Duckworth G., Farrington M., French G.L., et al. National glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health - August 2004. J Hosp Infect 2006, 62(Suppl. 1):S1-S27. 10.1016/j.jhin.2005.04.011.
10. Cheah A.L.Y., Spelman T., Liew D., Peel T., Howden B.P., Spelman D., et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect 2013, 19:E181-E189.
11. Vydra J., Shanley R.M., George I., Ustun C., Smith A.R., Weisdorf D.J., et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012, 55:764-770.
12. Howden B.P., Holt K.E., Lam M.M.C., Seemann T., Ballard S., Coombs G.W., et al. Genomic insights to control the emergence of vancomycin-resistant enterococci. MBio 2013, 4. e00412-13.